<Record>
<Term>Nitric Oxide Donors</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Molecular Mechanisms of Pharmacological Action</ParentTerm>
<ParentTerm>Cardiovascular Agents</ParentTerm>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Molecular Mechanisms of Pharmacological Action/Nitric Oxide Donors</ClassificationPath>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Therapeutic Uses/Cardiovascular Agents/Nitric Oxide Donors</ClassificationPath>
<BroaderTerm>Therapeutic Uses</BroaderTerm>
<BroaderTerm>Pharmacologic Actions</BroaderTerm>
<BroaderTerm>Nitric Oxide Donors</BroaderTerm>
<BroaderTerm>Chemical Actions and Uses</BroaderTerm>
<BroaderTerm>Cardiovascular Agents</BroaderTerm>
<BroaderTerm>Molecular Mechanisms of Pharmacological Action</BroaderTerm>
<Synonym>Nitric Oxide Donors</Synonym>
<Description>A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81)</Description>
<Source>MeSH</Source>
</Record>
